Search clinical trials for: Growth Substances

Total 7132 results

Hospital de Clinicas de Porto Alegre

Unknown

Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty

Cicatrix | Surgical Procedure, Unspecified | Rhinoplasty | Surgery, Plastic | Healing Scar

Brazil
National Cancer Institute (NCI)

Completed

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Breast Cancer

United States
Genentech, Inc.

Completed

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Choroidal Neovascularization, Age-related Macular Degeneration
Beth Israel Deaconess Medical Center

Terminated

Lenalidomide After Allo Transplant

Lymphoma | Multiple Myeloma

United States
National Cancer Institute (NCI)

Completed

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Melanoma

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Celgene Corporation

Terminated

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Myelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5q

United States
Novartis Pharmaceuticals

Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (EXTEND II)

Age Related Macular Degeneration

China
Fundació Institut Germans Trias i Pujol

Completed

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Diabetic Macular Edema | Vitreomacular Interface | Anti-VEGF Treatment
Poitiers University Hospital

Completed

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Multiple Myeloma | Impaired Renal Function

France
LEANDRO CABRAL ZACHARIAS
Novartis

Unknown

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Glaucoma, Neovascular | Ranibizumab
Centre Hospitalier Universitaire de Besancon

Unknown

Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer (COBEQOL)

Quality of Life | Metastatic Colorectal Cancer

France
Hadassah Medical Organization
Bayer

Unknown

Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.

Neovascular Age-related Macular Degeneration

Israel
Washington University School of Medicine

Completed

Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Myelodysplastic Syndromes

United States
Memorial Sloan Kettering Cancer Center
Celgene Corporation

Withdrawn

Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma

Lymphoma | Follicular Lymphoma
Haukeland University Hospital
Hoffmann-La Roche; Norwegian Cancer Society

Completed

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

Metastatic Melanoma

Norway
Hawaii Pacific Health
Genentech, Inc.

Completed

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)

Polypoidal Choroidal Vasculopathy

United States
Novartis Pharmaceuticals

Completed

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) (RESPOND)

Diabetic Macular Edema

Canada
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Unknown

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Osteosarcoma

China
Brandon G. Busbee, MD
Genentech, Inc.

Completed

Evaluation of Dosing Interval of Higher Doses of Ranibizumab (BGB/IST)

Macular Degeneration | Choroidal Neovascularization

United States
Genentech, Inc.

Completed

A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Macular Degeneration

United States
Hospital Regional de São José - Dr. Homero de Miranda...

Unknown

Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

Diabetic Retinopathy | Vitreous Hemorrhage

Brazil
National Cancer Institute (NCI)

Completed

Endostatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Arrowhead Regional Medical Center

Completed

Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management

Pterygium

United States
Russian Academy of Medical Sciences

Unknown

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Russian Federation
University of Miami

Completed

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Neovascular Age-related Macular Degeneration

United States
Lawson Health Research Institute
Novartis Pharmaceuticals

Completed

Lucentis to Treat Pigment Epithelial Detachment

Pigment Epithelial Detachment

Canada
Instituto de Olhos de Goiania

Completed

The Effect of Bevacizumab on Corneal Neovascularization (BQ-1-08-ARVO)

Corneal Neovascularization
Seoul Retina Investigator Group
Samsung Medical Center; Kyungpook National University Hospital

Unknown

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Branch Retinal Vein Occlusion

Korea, Republic of
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Isfahan Ophthalmology Research Center

Unknown

Intravitreal Bevacizumab for Diabetic Macular Edema

Diabetic Retinopathy | Macular Edema
Novartis

Completed

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Macular Degeneration (ARMD)

Switzerland
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Central Retinal Vein Occlusion | Severe Diabetic Retinopathy | Chronic Inflammation | Infectious Diseases

United States
University of Miami
Genentech, Inc.

Completed

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Neovascular Age-Related Macular Degeneration

United States
Premiere Oncology of Arizona
Genentech, Inc.

Unknown

Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

Lymphedema

United States
Wuhan Union Hospital, China

Not yet recruiting

Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric

Radiotherapy | Immunotherapy | Gastric/Gastroesophageal Junction Adenocarcinoma
Shin Kong Wu Ho-Su Memorial Hospital

Recruiting

Maximum Treatment Interval With Aflibercept T&E

Neovascular Age-related Macular Degeneration

Taiwan
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema

Diabetic Macular Edema

China
Pfizer

Recruiting

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant (MagnetisMM-7)

Multiple Myeloma

Japan, Belgium, United States, Netherlands, Australia, Austria, Taiwan, China, Spain, Canada, Israel, Germany, Italy, Czechia, Korea, Republic of, Norway, Finland, France, Sweden, Brazil, Greece, Turkey, United Kingdom, Hungary, Poland, I...
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury (BRAIN)

Brain Injuries

China
British Columbia Cancer Agency

Recruiting

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Canada
Nanjing Medical University
Second Affiliated Hospital of Soochow University

Recruiting

Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer (ChESS)

Uterine Cervical Neoplasms

China
Celgene

Recruiting

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Lymphoma

Japan
Moorfields Eye Hospital NHS Foundation Trust
Bayer

Completed

Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study (AMOUR)

Retinitis Pigmentosa | Macular Oedema

United Kingdom
Shanghai Henlius Biotech

Active, not recruiting

A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Age Related Macular Degeneration

United States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
IRCCS San Raffaele
Celgene

Completed

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma (RV-NHL-PI351)

Diffuse Large B-cell Lymphoma

Italy
Ophthotech Corporation

Completed

A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Age-related Macular Degeneration
Greater Houston Retina Research
Regeneron Pharmaceuticals; Clinical Trials Resource Group, LLC

Active, not recruiting

Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial (VOYAGE)

Diabetic Retinopathy

United States, Puerto Rico
Michel Giunta
Bayer

Active, not recruiting

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Wet Age-related Macular Degeneration

Canada
Qilu Pharmaceutical Co., Ltd.

Completed

A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
Federation Francophone de Cancerologie Digestive

Completed

Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers (FOLFA)

Colorectal Neoplasms

France

Search clinical trials for: Growth Substances

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations